API | vitamin a

vitamin a Report issue

Small molecule Approved ^FDA

AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW

Retonol, also known as Vitamin A1, is a vitamin found in food and used as a dietary supplement. It is used to treat and prevent vitamin A deficiency. It is also used to prevent further issues in those who have measles. Retinol is used as a metabolic precursor of retinoic acid to treat skin-related conditions, such as cellulite, skin aging, photodamage. ^NCATS

Chemistry

SMILES: CCCCCCCCCCCCCCCC(=O)OC/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
InChIKey: VYGQUTWHTHXGQB-FFHKNEKCSA-N
Mol. Mass: 524.87
ALogP: 11.54 Partition coefficient
ChEMBL Molecules:

vitamin a palmitate

retinyl acetate

retinol

More Chemistry

Pharmacology

Mechanism of Action:
Multi-specific: Missing data
Black Box: No
Availability: Prescription Only
Delivery Methods: Oral, Parenteral
Pro Drug: No

Drug Pricing (per unit)

United States

$44.6900

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

berocca pn ( vitamin e, folic acid, cyanocobalamin (berocca), vitamin c, nicotinamide, thiamine, biotin, panthenol, pyridoxine, riboflavin, vitamin a, ergocalciferol (drisdol) - other names: m.v.c, mvc plus )

infuvite ( vitamin d3, vitamin e, folic acid, cyanocobalamin (berocca), vitamin c, nicotinamide, thiamine, vitamin k, biotin, panthenol, pyridoxine, riboflavin, vitamin a - other names: infuvite pediatric, infuvite pediatric (pharmacy bulk package) )

m.v.i. adult (pharmacy bulk package) ( vitamin e, folic acid, cyanocobalamin (berocca), vitamin c, nicotinamide, thiamine, vitamin k, biotin, panthenol, pyridoxine, riboflavin, vitamin a, ergocalciferol (drisdol) )

m.v.i. pediatric ( vitamin e, folic acid, cyanocobalamin (berocca), vitamin c, nicotinamide, thiamine, biotin, panthenol, pyridoxine, riboflavin, vitamin a, phytonadione (konakion), ergocalciferol (drisdol) )

vitape ( vitamin e, folic acid, cyanocobalamin (berocca), vitamin c, nicotinamide, thiamine, pantothenic acid, biotin, pyridoxine, riboflavin, vitamin a, phytonadione (konakion), ergocalciferol (drisdol) )

Organizations (210)

Research & Development (185)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (25)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (79)

Approved Indications (2)

Measles (approved 1949)

Vitamin A Deficiency (approved 1949)

Experimental Indications - Clinical Trial Phases 1-4 (78)

Acne Vulgaris ()

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 3)

Asthma (Phase 2)

Atherosclerosis (Phase 4)

Attention Deficit Disorder with Hyperactivity (Phase 4)

Bronchopulmonary Dysplasia (Phase 1/Phase 2)

Burns (Phase 1)

Carcinoma, Non-Small-Cell Lung (Early Phase 1)

Central Serous Chorioretinopathy (Phase 2)

Cognitive Dysfunction (Phase 2)

Communicable Diseases (Phase 3)

COVID-19 (Phase 2)

Cytochrome P-450 CYP2D6 (Phase 1)

Dark Adaptation (Phase 2)

Dermatology (Phase 4)

Diabetes Mellitus (Phase 2/Phase 3)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Foot (Phase 2/Phase 3)

Diarrhea (Phase 4)

Dry Eye Syndromes (Phase 4)

Enterocolitis, Necrotizing (Phase 3)

Eye Diseases (Early Phase 1)

Growth and Development (Phase 3)

Healthy Volunteers (Phase 2)

Helminthiasis (Phase 4)

HIV (Phase 2)

HIV Infections (Phase 3)

HIV Seronegativity (Phase 2)

Infant, Low Birth Weight (Phase 1/Phase 2)

Infant Mortality (Phase 4)

Infant, Newborn (Phase 3)

Infant, Premature (Phase 1/Phase 2)

Infant, Small for Gestational Age (Phase 1/Phase 2)

Infections (Phase 2)

Infectious Disease Transmission, Vertical (Phase 3)

Influenza A Virus, H1N1 Subtype (Phase 4)

Iron Deficiencies (Phase 3)

Kidney Calculi (Phase 4)

Kidney Transplantation (Early Phase 1)

Lung Neoplasms (Phase 4)

Macular Degeneration (Early Phase 1)

Malaria (Phase 3)

Malaria Vaccines (Phase 3)

Malnutrition (Phase 3)

Maternal Health (Phase 3)

Maternal Mortality (Phase 3)

Meningitis (Phase 3)

Morbidity (Phase 3)

Mortality (Phase 4)

Multiple Sclerosis, Relapsing-Remitting (Phase 4)

Mycobacterium tuberculosis (Phase 3)

Non-alcoholic Fatty Liver Disease (Early Phase 1)

Obesity (Phase 4)

Optic Atrophy, Hereditary, Leber (Phase 1)

Ovarian Neoplasms (Phase 1/Phase 2)

Pediatrics (Phase 4)

Pneumonia (Phase 4)

Premature Birth (Phase 4)

Purpura (Phase 4)

Purpura, Thrombocytopenic, Idiopathic (Phase 2/Phase 3)

Respiration, Artificial (Phase 1/Phase 2)

Respiratory Distress Syndrome, Newborn (Phase 3)

Respiratory Tract Infections (Phase 4)

Retinitis Pigmentosa (Phase 3)

Retinopathy of Prematurity (Phase 4)

Rhytidoplasty (Phase 2)

Sepsis (Phase 4)

Skin Aging (Phase 4)

Skin Care (Early Phase 1)

Skin Diseases (Phase 2)

Skin Neoplasms (Early Phase 1)

Surface-Active Agents (Phase 3)

Vitamin A (Phase 3)

Vitamin A Deficiency (Phase 3)

Vitamins (Phase 2/Phase 3)

Wet Macular Degeneration (Early Phase 1)

Zinc (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 147
# of Trial Organizations: 185

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue